SARS-COV-2 DISEASE

Clinical trials for SARS-COV-2 DISEASE explained in plain language.

Never miss a new study

Get alerted when new SARS-COV-2 DISEASE trials appear

Sign up with your email to follow new studies for SARS-COV-2 DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can standard COVID drugs protect the most vulnerable? french study investigates.

Disease control Not yet recruiting

This study aims to understand how well two common antiviral drugs (nirmatrelvir/ritonavir and remdesivir) worked for immunocompromised adults hospitalized with COVID-19. Researchers will look back at the medical records of about 300 patients in France from mid-2023 to early 2024.…

Matched conditions: SARS-COV-2 DISEASE

Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Mar 12, 2026 13:50 UTC

SARS-COV-2 DISEASE

Get alerted when new SARS-COV-2 DISEASE trials appear

Can standard COVID drugs protect the most vulnerable? french study investigates.